Healthcare sector in India is one of the largest in terms of employment as well as in revenue. Around 80 % of healthcare rests with private sector. The government healthcare is basically covered in rural area with primary healthcare centre, which provides succour to basic ailments. It also has speciality hospitals in major cities and reputed healthcare in metro cities. However, it is the private sector that provides majority of secondary, tertiary and quaternary care institutions with a major concentration in metros, tier I and tier II cities.
India also provides contrast in healthcare with high malnutrition, higher infant mortality rate, under vaccinated children and on the other side, India have medical tourism with world class facilities. The Indian healthcare industry is
Kerala Government is planning to produce anti-rabies vaccine in the state. It will produce the vaccine at the Institute of Animal Health and Veterinary Biologicals (IAH&VB) at Palode near Thiruvananthapuram, under the state Animal Husbandry Department. The institute at present produces viral and bacterial vaccines against cattle and poultry diseases. It plans to produce a total of 10 million doses of both human and animal anti-rabies vaccine. Currently, the state procures vaccine from Hyderabad-based Indian Immunologicals Limited (IIL), a subsidiary of National Dairy Development Board.
Indian government has launched Bedaquiline, a new anti-TB drug for Drug Resistant TB (DR TB) as part of the Revised National Tuberculosis Control Program (RNTCP). The drug is a new anti-TB drug for treatment of MDR-TB. This new class of drug is a diarylquinoline that specifically targets Mycobacterial ATP synthase, an enzyme essential for supply of energy to Mycobacterium tuberculosis and most other mycobacteria. This drug is indicated for use in the treatment of drug-resistant TB. Bedaquiline is being introduced at six identified tertiary care centres across India. These sites have advanced facilities for laboratory testing and intensive care for patients. Bedaquiline will be given to multi-drug resistant TB patients with resistance to either all fluoroquinolone and/or all second line inj
King's College Hospital, one of the UK's largest teaching hospitals is planning set up a 1,000-bed world-class medical facility in Andhra Pradesh's new capital Amaravati in Andhra Pradesh. The UK based company is also planning to set up 11 hospitals around India with a capacity of 11000 beds. Indo UK Healthcare, a division of the group is venturing to set up its first hospital in Chandigarh in Haryana.
Aditi Healthcare, Rajkot-based company has launched an alcohol-free hand sanitizer under the name 'ZapCare'. Unlike alcohol-based sanitizers, the water-based product kills germs without having a drying effect on the skin. It is a foaming, non-alcohol instant antimicrobial hand sanitizer that does not have medicinal odour, contains aloe vera for moisturising the skin and vitamin-E that ensures that the skin does not dry out. The sanitizer does not require rinsing and will have to be rubbed on the hands and let to dry.
Indian Council of Medical Research is set to launch an indigenous and cost-effective diagnostic tool for tuberculosis (TB) by 2016. A Bengaluru-based company has made the new diagnostic tool is as good as GeneXpert test. The idea is to reduce the cost and have an indigenous diagnostic tool, where GeneXpert test is imported. The evaluation will be over in the next three months. If it is found to be good, production will be scaled up. That may take another six months or so. It maybe a year before the diagnostic tool is available. ICMR is also working on developing vaccines for major infections, malaria and HIV. The phase-one trial for malaria vaccine should start very soon as the necessary approvals have been obtained. It has applied for regulatory clearance to start the phase-three trial
Maharashtra government is in the process of formulating a new policy for dialysis centres, the guidelines of which will need to be strictly adhered to by health centre. The move comes after number of complaints of patients being treated carelessly at such centres came to light. One of the major guideline for the centres is likely to restrict the number of dialysis to three in a day. There were also complaints of lack of basic standard parameters at dialysis centres. The health department, taking suo moto cognisance of the troubles being faced by patients, thus decided to formulate a policy. Though there are a sizable number of patients, the number of nephrologists is only about 1,400 and the technical staff is even lesser in number. There is a need to increase the number of technical staff
Government of India and Gavi, the Vaccine Alliance, have announced a partnership that will help save the lives of millions of Indian children through increased access to vaccines. India is due to begin transitioning away from Gavi support from 2017 and is expected to begin fully self-financing all its vaccine programmes by 2021. The new partnership will accelerate the introduction of modern, highly-efficacious vaccines in India, protecting children against the leading causes of disease, including pneumonia and severe diarrhoea. Support will also be made available for the measles-rubella combined vaccine, future assistance to human papillomavirus vaccine. Currently 60 per cent of all Gavi-procured vaccines are manufactured in India. Through the partnership, Gavi and the Government of Ind
India is set to introduce injectable polio vaccine (IPV) in its universal immunisation programme (UIP) in a phased manner from November 2015. IPV will be over and above the oral polio vaccine. From April, 2016 the trivalent polio vaccine that is currently administered will be replaced by the bivalent variety to reduce incidence of vaccine-derived polio virus. In the first phase of IPV introduction, 17 high-risk states and four Union Territories will be covered. These are Bihar, Chandigarh, Delhi, Gujarat, Haryana, Punjab, Rajasthan, Uttar Pradesh, Arunachal Pradesh, Manipur, Meghalaya, Mizoram, Nagaland, Sikkim, Tripura, Assam, Madhya Pradesh, Andaman and Nicobar islands, Lakshadweep, Dadra and Nagar Haveli and Daman and Diu. IPV is one of the three vaccines that were approved by the go
Municipal Corporation of Greater Mumbai has decided to set up five mother-child care centres (maternity hospitals). These centres will be set up in Chembur, Bhandup, , Kandivali, Marol and Thane. The project will be funded through National Urban Health Mission (NUHM). The first mother-care center will come up in Chembur and the next one will be set up in Marol. The hospitals will have new neo-natal intensive care units, in-built blood banks and blood storage rooms, intensive care units, paediatric units, operation theatres and general wards.